학술논문
Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
Document Type
Article
Author
Source
In Annals of Oncology October 2016 27(10):1895-1902
Subject
Language
ISSN
0923-7534